Attached files

file filename
EX-21.1 - Hancock Jaffe Laboratories, Inc.ex21-1.htm
EX-10.23 - Hancock Jaffe Laboratories, Inc.ex10-23.htm
EX-10.20 - Hancock Jaffe Laboratories, Inc.ex10-20.htm
EX-10.17 - Hancock Jaffe Laboratories, Inc.ex10-17.htm
EX-10.16 - Hancock Jaffe Laboratories, Inc.ex10-16.htm
EX-10.15 - Hancock Jaffe Laboratories, Inc.ex10-15.htm
EX-10.13 - Hancock Jaffe Laboratories, Inc.ex10-13.htm
EX-10.12 - Hancock Jaffe Laboratories, Inc.ex10-12.htm
EX-10.11 - Hancock Jaffe Laboratories, Inc.ex10-11.htm
EX-10.10 - Hancock Jaffe Laboratories, Inc.ex10-10.htm
EX-10.6 - Hancock Jaffe Laboratories, Inc.ex10-6.htm
EX-10.5 - Hancock Jaffe Laboratories, Inc.ex10-5.htm
EX-10.4 - Hancock Jaffe Laboratories, Inc.ex10-4.htm
EX-10.3 - Hancock Jaffe Laboratories, Inc.ex10-3.htm
EX-10.2 - Hancock Jaffe Laboratories, Inc.ex10-2.htm
EX-10.1 - Hancock Jaffe Laboratories, Inc.ex10-1.htm
EX-4.1 - Hancock Jaffe Laboratories, Inc.ex4-1.htm
S-1 - Hancock Jaffe Laboratories, Inc.forms-1.htm

 

Independent Registered Public Accounting Firm’s Consent

 

We consent to the inclusion in this Registration Statement of Hancock Jaffe Laboratories, Inc. on Form S-1 of our report dated September 6, 2017,which includes an explanatory paragraph as to the Company’s ability to continue as a going concern, with respect to our audits of the financial statements of Hancock Jaffe Laboratories, Inc. as of December 31, 2016 and 2015 and for the years ended December 31, 2016 and 2015, which report appears in the Prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading “Experts” in such Prospectus.

  

/s/ Marcum LLP

 

 

Marcum LLP

New York, NY

September 6, 2017